首页> 外文OA文献 >A phase 2 open-label study of carboplatin in combination with gemcitabine as a dose-dense schedule in patients with locally advanced or metastatic breast cancer that are resistant to anthracyclines and taxanes

【2h】

A phase 2 open-label study of carboplatin in combination with gemcitabine as a dose-dense schedule in patients with locally advanced or metastatic breast cancer that are resistant to anthracyclines and taxanes

机译：与吉西他滨组合的Carboplatin相结合的2个开放标签研究作为患有临时或转移性乳腺癌的患者的剂量密集的时间表，这些时间表抵抗蒽氟胺和紫杉烷

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Christopher Mansbridge; Peter Simmonds; Nicholas Murray; Andrew Davies; Louise Stanton; Fay Chinnery; Caroline Archer; Peter Barrett-Lee; Tamas Hickish; Simon Crabb;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. A phase 2 study of the combination of gemcitabine and cisplatin in patients with locally advanced or metastatic breast cancer previously treated with anthracyclines with/without taxanes [J] . Hanna Kohail, Samir Shehata, Omar Mansour, Hematology/Oncology and Stem Cell Therapy . 2012,第1期

机译：吉西他滨和顺铂联合治疗先前接受蒽环类药物联合/不联合紫杉类药物治疗的局部晚期或转移性乳腺癌患者的2期研究
2. Carboplatin and gemcitabine combination in metastatic triple-negative anthracycline- and taxane-pretreated breast cancer patients: a phase II study. [J] . Maisano R, Zavettieri M, Azzarello D, Journal of chemotherapy . 2011,第1期

机译：卡铂和吉西他滨联合治疗转移性三阴性蒽环类和紫杉烷类预处理的乳腺癌患者：II期研究。
3. Phase III Open-Label Randomized Study of Eribulin Mesylate Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane [J] . Kaufman Peter A., Awada Ahmad, Twelves Chris, Journal of Clinical Oncology . 2015,第6期

机译：甲磺酸依瑞布林和卡培他滨对先前用蒽环类和紫杉烷类药物治疗的局部晚期或转移性乳腺癌患者的III期开放标签随机研究
4. Gemcitabine + Cisplatin Combination Electrochemotherapy for Triple Negative Breast Cancers: An in vitro Model Study [C] . R. Sundararajan, V. Raman, V. Masterson World Congress on Electroporation and Pulsed Electric Fields in Biology, Medicine and Food Environmental Technologies . 2016

机译：Gemcitabine +顺铂组合电化学疗法三重阴性乳腺癌：体外模型研究
5. Enhancement of Gemcitabine and Paclitaxel Uptake and Retention in Metastatic Cancer Cells: A Novel Targeted Combination Delivery Approach to Eliminate Breast Cancer in Blood and Lymph [D] . Yu, Jesse. 2020

机译：吉西他滨和紫杉醇吸收的增强和转移性癌细胞的保留：一种小型靶向组合递送方法，消除血液和淋巴中的乳腺癌
6. Phase III Open-Label Randomized Study of Eribulin Mesylate Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane [O] . Peter A. Kaufman, Ahmad Awada, Chris Twelves, -1

机译：甲磺酸依瑞布林与卡培他滨对先前用蒽环类和紫杉烷类药物治疗的局部晚期或转移性乳腺癌患者的III期开放标签随机研究
7. A phase 2 study of the combination of gemcitabine and cisplatin in patients with locally advanced or metastatic breast cancer previously treated with anthracyclines with/without taxanes [O] . Kohail Hanna, Shehata Samir, Mansour Omar, 2012

机译：吉西他滨和顺铂联合治疗先前用蒽环类药物联合/不联合紫杉类药物治疗的局部晚期或转移性乳腺癌患者的2期研究

A phase 2 open-label study of carboplatin in combination with gemcitabine as a dose-dense schedule in patients with locally advanced or metastatic breast cancer that are resistant to anthracyclines and taxanes

著录项

引文网络

相似文献

相关主题

期刊订阅